Breaking Finance News

A statement released earlier today by RBC Capital about UnitedHealth (NYSE:UNH) raises the target price to $175.00

UnitedHealth (NYSE:UNH) had its target bumped up to $175.00 by RBC Capital in a report released 11/30/2016. The new stock price target indicates a possible upside of 0.11% from the company's most recent close.

Having a price of $157.59, UnitedHealth (NYSE:UNH) traded 3.60% higher on the day. With the last stock price close up 12.22% from the 200-day moving average, compared to the S&P 500 which has decreased -0.03% over the same time. The company has recorded a 50-day moving average of $143.81 and a 200-day moving average of $139.88. 5,827,585 shares of UNH traded hands, up from an average trading volume of 3,746,020

See Chart Below

UnitedHealth (NYSE:UNH)

UnitedHealth has a one year low of $107.51 and a one year high of $158.12 with a PE ratio of 23.19 UNH’s total market value is presently $0.

A total of 24 equity analysts have issued a report on the stock. 10 firms rating the company a strong buy, twelve brokerages rating the company a buy, three brokers rating the stock a hold, 1 broker rating the stock a underperform, and finally zero analysts rating the company a sell with a 12-month price target of $144.17.

More About UnitedHealth (NYSE:UNH)

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum. UnitedHealthcare provides healthcare benefits to a range of customers and markets through its UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State, and UnitedHealthcare Global businesses. Optum is a health services business serving the healthcare marketplace, including payers, care providers, employers, governments, life sciences companies and consumers, through its OptumHealth, OptumInsight and OptumRx businesses.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *